FilingReader Intelligence

Torrent Pharmaceuticals issues ₹200 crore commercial papers

September 24, 2025 at 07:03 PM UTCBy FilingReader AI

Torrent Pharmaceuticals Limited has issued commercial papers (CPs) totaling ₹200 crore. The announcement, made on September 24, 2025, details the issuance under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These CPs will be listed on the National Stock Exchange of India (NSE).

The commercial papers have a tenure of 90 days, with the allotment date being September 24, 2025, and maturity/redemption scheduled for December 23, 2025. The coupon/interest/discount rate for these papers is 5.93% per annum, payable upfront. Principal payment will occur at maturity, and the instruments are unsecured.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Torrent Pharmaceuticals publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →